课题基金 / 基金详情

KELOID TISSUE & HYPERTROPHIC SCAR: GENETICS, BIOTECHNOLOGY: MINORITY HLTH SKIN

KELOID TISSUE & HYPERTROPHIC SCAR: GENETICS, BIOTECHNOLOGY: MINORITY HLTH SKIN
瘢痕疙瘩组织
批准号:
6121446
负责人:
PAUL A KELLY
金额:
$11.0万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-06-01 至 2000-09-29

项目摘要

项目成果

PAUL A KELLY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall aim of our studies is to determine the cellular and molecular mechanisms that lead to keloid growth. Establish primary fibroblast cultures from keloid and non-keloid tissues. Investigate mechanisms of the amino acid transport to proline as a precursor of increased collagen synthesis in keloids. To determine if specific growth factors (TGF-", TNF-", "FGF, BFGF, PDGF and EGF) and cytokines will influence keloid growth, by regulating amino acid transport, & expression of matrix proteins such as collagen(s)and fibronectin. To investigate the role of the tumor suppressor genes p53, RB, CDD in keloids. And establish HLA typing in combination with PRC technology for keloid samples. To accomplish these goals we are using keloid tissue from patients who seek our services for removal of cosmetically unacceptable and/or symptomatic keloidsl
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
KELOID TISSUE & HYPERTROPHIC SCAR: GENETICS, BIOTECHNOLOGY: MINORITY HLTH SKIN
KELOID TISSUE & HYPERTROPHIC SCAR: GENETICS, BIOTECHNOLOGY: MINORITY HLTH SKIN
KELOID TISSUE & HYPERTROPHIC SCAR: GENETICS, BIOTECHNOLOGY: MINORITY HLTH SKIN
KELOID TISSUE & HYPERTROPHIC SCAR: GENETICS, BIOTECHNOLOGY: MINORITY HLTH SKIN
海外基金